News | November 12, 2021
Natco Pharma PAT at Rs 65.1 cr. in Q2FY22
Natco Pharma has reported consolidated financial results for the period ended September 30, 2021
Natco Pharma has reported consolidated financial results for the period ended September 30, 2021
The ground-breaking project, led by Genomics England and NHS England, was established in 2013 to sequence 100,000 whole genomes from NHS patients and their families
Solara Active Pharma Sciences has reported consolidated financial results for the period ended September 30, 2021.
J. B. Chemicals & Pharmaceuticals Limited (JBCPL), announced its financial results for the second quarter ended 30th September, 2021
The company expects to begin shipping this product before the end of its fiscal first quarter, ending December 31, 2021
The centre has an initial capacity of 500 FTEs
The Drug Controller General of India (DCGI), is reviewing clinical data of molnupiravir for the treatment of Covid-19 in adults in India
The Board of Directors of Alembic Pharmaceuticals have approved the unaudited consolidated financial results of the company for the period ended September 30, 2021.
Metropolis Healthcare has reported consolidated financial results for the period ended September 30, 2021
LSDCheck is CE-IVD approved LCMSMS-based testing kit for LSD in newborns
Subscribe To Our Newsletter & Stay Updated
